Product Information
TIMOLOL 0.5% GEL-SOLUTION is a generic product labeled by Fosun Pharma USA Inc., priced at $8.3020 per ML under NDC 72266020001. Its NADAC has been published 160 times since Sep 13, 2023.
FDA first approved this application on Jun 24, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/mL
Manufacturer
Fosun Pharma USA Inc.NDC
72266020001
Classification
Generic
Dosage Form
SOLUTION, GEL FORMING / DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TIMOLOL MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA214645FDA Approved
6/24/2022
TE Code
AB
On Market Since
3/15/2023
Pharmacological Classes
Price Statistics
The NADAC for TIMOLOL 0.5% GEL-SOLUTION has been published 160 times since Sep 13, 2023, and over the history we have for it it has declined 65.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.3020 per ML |
|---|---|
| All-time high | $23.9738 (Nov 15, 2023) |
| All-time low | $8.3020 (Sep 23, 2026) |
| 52-week high | $13.9013 |
| 52-week low | $8.3020 |
| Median price | $13.6718 |
| Average price | $14.2446 |
| Largest weekly change | +60.2% (Aug 21, 2024) |
| Weeks tracked | 160 |
| Tracking since | Sep 13, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Timolol Maleate Ophthalmic Gel Forming Solution market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fosun Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Timolol Maleate Ophthalmic Gel Forming Solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIMOLOL 0.5% GEL-SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL 0.5% GEL-SOLUTION, manufactured by Fosun Pharma USA Inc., is $8.3020 per ML (NDC 72266020001), effective Sep 30, 2026.
How has the price of TIMOLOL 0.5% GEL-SOLUTION changed over time?
Over the history we have for it, the NADAC for TIMOLOL 0.5% GEL-SOLUTION has declined 65.1%. It has been tracked across 160 weekly CMS publications since Sep 13, 2023.
What are the highest and lowest recorded NADAC prices for TIMOLOL 0.5% GEL-SOLUTION?
Since Sep 13, 2023, the NADAC for TIMOLOL 0.5% GEL-SOLUTION has ranged from a low of $8.3020 (Sep 23, 2026) to a high of $23.9738 (Nov 15, 2023), with a median of $13.6718 per ML.
Are there cheaper alternatives to TIMOLOL 0.5% GEL-SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of TIMOLOL 0.5% GEL-SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TIMOLOL 0.5% GEL-SOLUTION?
TIMOLOL 0.5% GEL-SOLUTION (NDC 72266020001) is labeled by Fosun Pharma USA Inc., and CMS classifies it as a generic product.